1AD ASX Chart
Snapshot
AdAlta Limited (1AD) is a clinical stage biotechnology company and is involved in the discovery and development of next generation cell and protein-based therapeutics.
Share Price Activity (ASX)
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2026 YTD | |
| 1 Year | |
| vs Sector (1yr) | +95.37% |
| vs ASX 200 (1yr) | +57.38% |
Announcements
Corporate Overview
Corporate Details
| Head Office | Hawthorn East VIC 3123 |
| Website | www.adalta.com.au |
| Registry | Automic Group |
| Auditor | Dry Kirkness (Audit) Pty Ltd |
| Date Listed | 22 Aug 2016 |
Upcoming Calendar (Forecasted)
| Date | Event |
|---|---|
| 26/08/2026 | Report (Prelim) |
| 26/08/2026 | Report (Annual) |
| 19/02/2027 | Report (Interim) |
Former Company Names
- Adalta Ltd has no former company names.
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
1AD directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of 1AD directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
| Name | Last Notice | Total Shares | Shares Held (%) |
|---|---|---|---|
| Chunyan Niu | 04/08/2025 | 66,666,667 | 5.99 |
| HSBC Custody Nominees (Australia) Limited | 04/08/2025 | 92,345,364 | 8.30 |
| David Dominic Pevcic | 04/12/2025 | 168,095,264 | 7.32 |
| New Life Science Capital LLC | 16/09/2025 | 225,015,037 | 15.41 |
| Meurs Holdings Pty Ltd | 04/12/2025 | 293,480,026 | 12.79 |
| Stuart Morris | 04/12/2025 | 166,108,388 | 7.24 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
| Date | Name | Bought | Previous % | New % |
|---|---|---|---|---|
| 04-12-25 | David Dominic Pevcic | 13,009,463 | 9.17 | 7.32 |
| 28-10-25 | Meurs Holdings Pty Ltd | 239,885,858 | 12.14 | 15.51 |
| 20-10-25 | David Dominic Pevcic | 155,085,801 | -- | 9.17 |
| 16-09-25 | New Life Science Capital LLC | 136,089,389 | 6.73 | 15.41 |
| 27-08-25 | Stuart Morris | 68,666,666 | 16.36 | 12.57 |
| 27-08-25 | New Life Science Capital LLC | 166,666,667 | -- | 12.61 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
| Date | Name | Sold | Previous % | New % |
|---|---|---|---|---|
| 20-10-25 | Platinum Investment Management Limited | 78,814,880 | 5.40 | -- |
| 10-09-25 | New Life Science Capital LLC | 58,097,902 | 11.13 | 6.73 |
| 08-09-25 | New Life Science Capital LLC | 19,643,117 | 12.61 | 11.13 |
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2025 | $0.002 | 30 June |
| 2024 | $0.026 | 28 June |
| 2023 | $0.024 | 30 June |
| 2022 | $0.054 | 30 June |
| 2021 | $0.125 | 30 June |
| 2020 | $0.085 | 30 June |
| 2019 | $0.16 | 28 June |
| 2018 | $0.37 | 29 June |
| 2017 | $0.28 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.